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Ebf1 is an important determinant of the specification of
B lymphocytes. However, expression of this transcription
factor is not limited to early B lymphopoiesis and con-
stitutive deletion of Ebf1 results in developmental block
and embryonic lethality. To gain insight into additional
functions of Ebf1, we inactivated Ebf1 at various stages
of differentiation using a Cre-lox-regulated conditional
knockout allele.
We found that Ebf1 is required for the proliferation
and survival of pro-B cells and peripheral B-cell subsets.
In Ebf1-deficient pro-B cells, overexpression of the pro-
survival genes Bcl2 or BclXL was not sufficient for cell–
survival.
We found a remarkable clonal difference in the cell
cycle response of transformed pro-B cells upon induced
Ebf1-deletion: one cell type arrested in the G(1) phase
and the other type died without arrest. Unexpectedly, the
cycling cell-type survived upon c-myb overexpression, in
contrast to the other transformed clone type or to pri-
mary pro-B cells, showing cell cycle arrest as well. This
point to two different Ebf1 regulated cell-cycle-coupled
cell survival pathways. As inactivating mutations of the
EBF1 gene are frequent in acute lymphoblastic leukaemia,
elucidating the role of Ebf1 in cell cycle and survival
could provide novel means of intervention in the growth
of leukaemia cells.
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